bibliographicCitation |
Chen CS, Papayannopoulos IA, Timmons S, Chou S, Thiagarajan P. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets. Biochimica et Biophysica Acta (BBA) - General Subjects. 1991 Oct;1075(3):237–47. doi: 10.1016/0304-4165(91)90272-i. |